Lisa Bender, M.S. CCC-SLP/A Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 605 Mineral Springs St, Orrville, OH 44667 Phone: 330-682-1851 |
Kaitlyn Ledington, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 605 Mineral Springs St, Orrville, OH 44667 Phone: 330-682-1851 |
News Archive
QLT Inc. today announced final 24-month results from the Phase II RADICAL study (Reduced Fluence Visudyne Anti-VEGF-Dexamethasone In Combination for AMD Lesions) in patients with exudative (wet) age-related macular degeneration. The purpose of the study was to determine if Visudyne® combined with Lucentis® reduced retreatment rates compared with Lucentis monotherapy, while maintaining similar vision outcomes and an acceptable safety profile.
The holiday season can be an especially trying time of year for those in recovery. The California Association of Marriage and Family Therapists offers tips for those suffering with addiction to help prevent relapse.
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
Does life really begin at 40? Is 50 the new 30? For people in these age groups, the answer appears to be yes.
› Verified 8 days ago